Remarkable increase in fluoroquinolone-resistant mycoplasma genitalium in Japan

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 9, 2014, Pages 2376-2382

  Kikuchi, Mina ^a   Ito, Shin ^b   Yasuda, Mitsuru ^a   Tsuchiya, Tomohiro ^a   Hatazaki, Kyoko ^a   Takanashi, Masaki ^c   Ezaki, Takayuki ^a   Deguchi, Takashi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IClinic   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

23S rRNA; Azithromycin; GyrA; ParC; Sitafloxacin

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING) A; MACROLIDE; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 23S; SITAFLOXACIN; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE; RIBOSOME DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; CLINICAL ARTICLE; GENOTYPE; HUMAN; JAPAN; MALE; MYCOPLASMA GENITALIUM; NONSPECIFIC URETHRITIS; RETROSPECTIVE STUDY; URINALYSIS; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MUTATION; MYCOPLASMA INFECTIONS; PREVALENCE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; JAPAN; MACROLIDES; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 84905979525     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku164     Document Type: Article

References (31)

1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24: 498-514.
2. Deguchi T, Ito S, Hagiwara N et al. Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis. Expert Rev Anti Infect Ther 2012; 10: 791-803.
3. Jensen JS, Bradshaw CS, Tabrizi SN et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47: 1546-53.
4. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12: 1149-52.
5. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45: 1-12.
6. Fraser CM, Gocayne JD, White O et al. The minimal gene complement of Mycoplasma genitalium. Science 1995; 270: 397-403.
7. Ito S, Shimada Y, Yamaguchi Y et al. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect 2011; 87: 412-4.
8. Yew HS, Anderson T, Coughlan E et al. Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis. J Clin Microbiol 2011; 49: 1695-6.
9. Liu P, Allaudeen H, Chandra R et al. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Antimicrob Agents Chemother 2007; 51: 103-9.
10. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3: e3618.
11. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19: 676-9.
12. Hamasuna R, Jensen JS, Osada Y. Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother 2009; 53: 4938-9.
13. Ito S, Yasuda M, Seike K et al. Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J Infect Chemother 2012; 18: 414-8.
14. Takahashi S, Hamasuna R, YasudaM et al. Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 2013; 19: 941-5.
15. Waites KB, Lysnyansky I, Bebear C. Emerging antimicrobial resistance in mycoplasmas of humans and animals. In: Browning GF, Citti C, eds. Mollicutes: Molecular Biology and Pathogenesis. Norwich: Caister Academic Press, 2014; 289-322.
16. Shimada Y, Deguchi T, Nakane K et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents 2010; 36: 255-8.
17. Tagg KA, Jeoffreys NJ, Couldwell DL et al. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol 2013; 51: 2245-9.
18. Yoshida H, Bogaki M, Nakamura M et al. Quinolone resistancedetermining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990; 34: 1271-2.
19. Couldwell DL, Tagg KA, Jeoffreys NJ et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 2013; 24: 822-8.
20. Yoshida T, Maeda S, Deguchi T et al. Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol 2003; 41: 1850-5.
21. Shimada Y, Deguchi T, Nakane K et al. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg Infect Dis 2011; 17: 1148-50.
22. Hjorth SV, Bjö rnelius E, Lidbrink P et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol 2006; 44: 2078-83.
23. Ma L, Taylor S, Jensen JS et al. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 2008; 8: 130.
24. Musatovova O, Baseman JB. Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium. J Clin Microbiol 2009; 47: 1469-75.
25. Cazanave C, Charron A, Renaudin H et al. Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens. J Med Microbiol 2012; 61 Pt 4: 500-6.
26. Pond MJ, Nori AV, Witney AA et al. High prevalence of antibioticresistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58: 631-7.
27. TakahashiS, IchiharaK, Hashimoto J et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 2011; 17: 392-6.
28. Deguchi T, Maeda S, TamakiMet al. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J Antimicrob Chemother 2001; 48: 742-4.
29. Touati A, Peuchant O, Jensen JS et al. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol 2014; 52: 1549-55.
30. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 8: e61481.
31. Fábrega A, Madurga S, Giralt E et al. Mechanism of action of and resistance to quinolones. Microb Biotechnol 2009; 2: 40-61.